12885_2022_9397_MOESM1_ESM.docx (49.92 kB)

Additional file 1 of Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain

Download (49.92 kB)
journal contribution
posted on 2022-03-19, 04:30 authored by Federico Rojo, Esther Conde, Héctor Torres, Luis Cabezón-Gutiérrez, Dolores Bautista, Inmaculada Ramos, David Carcedo, Natalia Arrabal, J. Francisco García, Raquel Galán, Ernest Nadal
Additional file 1: Table 1. Efficacy (median PFS and median OS) and costs associated with each first-line treatments.